Rakovina Therapeutics Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| RKV.V | PCSA | APRE | ALLR | TPST | APVO | |
|---|---|---|---|---|---|---|
| Market cap | 4.27M | 5.41M | 6.36M | 17.18M | 9.26M | 2.90M |
| P/E (TTM) | — | — | — | — | — | 0.0 |
| Forward P/E | — | -0.5 | -1.3 | -1.3 | -0.4 | -0.1 |
| Price/book | -2.0 | -17.0 | 0.3 | 4.9 | -6.8 | 0.3 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +2.94% | −75.51% | −57.92% | −2.70% | −95.15% | −94.82% |
| Today | 0.00% | −0.26% | −1.90% | −4.42% | −1.13% | +0.74% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All RKV.V news ›Rakovina Therapeutics and Celvion Therapeutics Complete AI Analysis Identifying Priority Cancer Indications for Brain-Penetrant ATR Inhibitor Program
EMphora™ platform integrates clinical evidence and predictive modelling to help identify promising cancer patient populations and guide the next phase of research The analysis identified two priority cancer indications for a second,…
Rakovina Therapeutics and Variational AI Advance Brain-Penetrant ATR Program Toward Development Candidate Selection
Rakovina has advanced the program from target specification through lead generation and five cycles of iterative lead optimization in approximately two years, using Variational AI’s Enki™ generative AI platform together with focused…
Why Rakovina Therapeutics Inc. (TSXV:RKV) Is Funding AI-Led Cancer Drug Discovery After Raising C$1.99 Million in a Private Placement
kalkine.ca The short answer Rakovina Therapeutics (TSXV:RKV) is in the news because it has closed a non-brokered private Placement of C$1,991,000, up from an initial
Rakovina Therapeutics Secures Exclusivity on Optimized kt-5000 Lead Profile from Variational AI
Investing News Network Rakovina Therapeutics Secures Exclusivity on Optimized kt-5000 Lead Profile from Variational AI Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (OTCMKTS: RKVTF), a biopharmaceu
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- digitaljournal.com1
- investingnews.com1
- kalkine.ca1
- manilatimes.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.